Acadia Pharmaceuticals Inc. announced that its President, Srdjan (Serge) Stankovic, M.D., M.S.P.H., who is responsible for R&D, and Medical and Scientific functions, will retire at the end of the year. A search for a successor to Dr. Stankovic is ongoing. Following his retirement, Dr. Stankovic will provide consulting and advisory services for Acadia on a part-time basis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.1 USD | +0.67% | -0.66% | -51.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.77% | 2.49B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.
- Acadia Pharmaceuticals Inc. Announces Retirement of Srdjan Stankovic as President